| 40991 |
A |
II |
2024/12/23
|
SUZHOU RYWAY BIOTECH CO LTD |
THYMALFASIN |
| 41004 |
A |
II |
2024/12/23
|
ZHEJIANG KINGLAND PHARMACEUTICAL CO LTD |
L-ORNITHINE L-ASPARTATE |
| 41025 |
A |
II |
2024/12/23
|
AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD) |
EMPAGLIFLOZIN |
| 41016 |
A |
II |
2024/12/22
|
NOVOPROTEIN SCIENTIFIC (HEZE) INC |
T7 RNA POLYMERASE 2.0, GMP GRADE |
| 41035 |
A |
II |
2024/12/22
|
DIJIA PHARMACEUTICAL GROUP CO LTD |
GLIPIZIDE |
| 40714 |
A |
II |
2024/12/21
|
BIOCON LTD |
SEMAGLUTIDE |
| 40414 |
A |
II |
2024/12/20
|
SIEGFRIED AG |
NALTREXONE |
| 40737 |
A |
II |
2024/12/20
|
DASAMI LAB PRIVATE LTD |
VILOXAZINE HYDROCHLORIDE |
| 40751 |
A |
II |
2024/12/20
|
JIANGSU CHIA TAI FENGHAI PHARMACEUTICAL CO LTD |
DEXMEDETOMIDINE HYDROCHLORIDE |
| 40842 |
A |
II |
2024/12/20
|
MEDICHEM SA |
IVACAFTOR |
| 40976 |
A |
II |
2024/12/20
|
PINSHAN BIOTECHNOLOGY (SHANGHAI) CO LTD |
HIFTRA™ PEI GMP TRANSFECTION REAGENT |
| 41011 |
A |
II |
2024/12/20
|
BIOPHORE INDIA PHARMACEUTICALS PVT LTD |
SUVOREXANT PREMIX |
| 40742 |
A |
II |
2024/12/19
|
AZICO BIOPHORE INDIA PRIVATE LTD |
EMPAGLIFLOZIN |
| 40820 |
A |
IV |
2024/12/19
|
ANMOL CHEMICALS PRIVATE LTD |
LACTIC ACID USP |
| 40828 |
A |
II |
2024/12/19
|
JOYANG LABORATORIES |
MYCOPHENOLATE SODIUM |
| 39260 |
A |
II |
2024/12/19
|
CARDINAL HEALTH 414 LLC |
ACTINIUM (225AC) NITRATE SOLUTION |
| 40084 |
A |
V |
2024/12/19
|
REGENERON PHARMACEUTICALS INC |
REGENERON CELL LINE AND MANUFACTURING PROCESS DEVELOPMENT PLATFORM TECHNOLOGIES FOR RECOMBINANT ANTIBODY PRODUCTS |
| 40848 |
A |
II |
2024/12/19
|
TAPI NL BV |
SAMIDORPHAN L-MALATE |
| 40916 |
A |
IV |
2024/12/19
|
ANMOL CHEMICALS PRIVATE LTD |
SODIUM HYALURONATE BP |
| 40917 |
A |
IV |
2024/12/19
|
ANMOL CHEMICALS PRIVATE LTD |
SODIUM ACETATE (ANHYDROUS) USP |
请输入需要查询的关联主题/药物名称（英文），DMF持有人（英文），DMF号码